Review of Drug Use in Gilbert's Syndrome

Siest G Antoine B Fournel S Magdalou J Thomassin J . The glucuronyltransferases: What progress can pharmacologists expect from molecular biologic and cellular enzymology? Biochem Pharmacol 1987; 36: 983–9.

Shargel L Yu ABC , eds. Applied biopharmaceutics and pharmacokinetics. 2nd ed. Norwalk, CT: Appleton-Century-Crofts, 1985: 176–7.

Bock EW Lilienblum W Fisher G Schirmer G Bock-Hennig BS . Induction and inhibition of conjugating enzymes with the emphasis on UDP-glucuronyltransferases. Pharmacol Ther 1987; 33: 23–7.

Burke MD Vadi H Jernstorm B . Metabolism of benzo(a)pyrene with isolated hepatocytes and the formation and degradation of DNA-binding derivates. J Biol Chem 1977; 252: 6424–31.

Gilbert A Lereboullet P . La cholemie simple familiale. Sem Med 1901; 21: 241.

Scharchmidt BF . Bilirubin metabolism and hyperbilirubinemia. In: Wyngaarden JB Smith LH , eds. Cecil textbook of medicine. 17th ed. Philadelphia: WB Saunders, 1985: 806–8.

Powell LW Hemingway E Billing BH . An idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)—a study of 42 families. N Engl J Med 1967b; 277: 1108–12.

Powell LW Billing BH Williams HS . An increase of red blood cell survival in idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium. Aust Ann Med 1967a; 16: 221–5.

Fromke VL Miller D . Constitutional hepatic dysfunction (Gilbert's disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine (Baltimore) 1972: 51: 451–64.

Ohkubo H Okuda K . The nicotinic acid test in constitutional conjugated hyperbilirubinemias and effects of corticosteroid. Hepatology 1984; 4: 1206–8.

Macklon AF Savage RL Rawlins MD . Research review: Gilbert's syndrome and drug metabolism. Clin Pharmacokinet 1979; 4: 223–32.

Black M Fevery J Parker D . Effect of phenobarbitone on plasma (14C) bilirubin clearance in patients with unconjugated hyperbilirubinemia. Clin Sci Mol Med 1974; 46: 1–17.

Javor T Gogl A Horvath T . Effects of phenobarbital treatment on biliary excretion in man. Drug Metab Dispos 1973; 1: 424–7.

Dauglas AP Savage RL Rawlins MD . Paracetamol (acetaminophen) kinetics in patients with Gilbert's syndrome. Eur J Clin Pharmacol 1978; 13: 209–12.

Carulli N Ponz LM Mauro E . Alteration of drug metabolism in Gilbert's syndrome. Gut 1976; 17: 581–7.

Berk PO Blaschke TF Waggoner JG . Defective bromsulphthalein clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology 1972; 63: 472–81.

Reynolds JEF , ed. Martindale: The extra pharmacopoeia. 29th ed. London: The Pharmaceutical Press, 1989: 250.

Okolicsanyi L Venuti M Strazzabosco M . Pharmacokinetics of josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses. Int J Clin Pharmacol Ther Toxicol 1985; 23: 434–8.

Mandell GL Sande MA . Antimicrobial agents. In: Gilman AG Goodman LS Rall TW Murad F , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985: 1179–84.

Koup JR Lau AH Brodsky B . Chloramphenicol pharmacokinetics in hospitalized patients. Antimicrob Agents Chemother 1979; 15: 651–7.